"So you are telling me that this is going to be a real priority for the FDA and that you are going to get this rule through."
"So when does the FDA plan to use its regulatory authority to implement effective, standardized patient information for prescription drugs?"
"I really am asking a when question. What is your timeline for when we are going to get these identifications, this information, into the hands of consumers?"
"Are you saying you have some doubt about whether or not giving patients information that is effective, about how they should take their medications, is within the scope of the authority of the FDA?"
"if the FDA cannot commit to get this done in a reasonable time, then it is time for Congress to act."
"I want to apologize for being late. We are doing flood insurance on the floor and have a Banking hearing going on simultaneously."
"So, Dr. Woodcock, I actually--remember, I actually worked at one of these regulatory agencies and got this process started."
"I'm pleased that the IRS is including another study as part of its national research program."
"So we need some kind of regulatory structure around this."
"Yes, they do say that. For a reason."
"I understand that you're a proponent of trying to use objective data to guide enforcement policies."